Director dealings: Genus chairman snaps up shares
Genus
1,962.00p
09:54 16/09/24
Genus revealed on Friday that chairman Iain Ferguson had acquired 3,500 ordinary shares in the FTSE 250-listed biotechnology group.
FTSE 250
20,887.48
10:00 16/09/24
FTSE 350
4,564.09
10:00 16/09/24
FTSE All-Share
4,520.15
10:00 16/09/24
Pharmaceuticals & Biotechnology
23,020.97
10:00 16/09/24
Ferguson, who was took over the chairman's role in July 2020, purchased the shares on Thursday at an average price of 1,763.63p each, for a total value of £61,726.91.
As of 1640 BST, Genus shares were down 1.83% at 1,714.0p.
Reporting by Iain Gilbert at Sharecast.com
Top Director Buys
Cairn Homes (cdi) (CRN)
Director name: Stanley,Michael
Amount purchased: 8,000,000 @ 1.84
Value: 13,261,261.50
Genus (GNS)
Director name: Ferguson,Iain
Amount purchased: 3,500 @ 1,763.63p
Value: £61,726.91
Insig Ai (INSG)
Director name: Wilson ,John
Amount purchased: 400,000 @ 13.06p
Value: £52,240.00
Insig Ai (INSG)
Director name: Bernstein,Richard
Amount purchased: 400,000 @ 12.69p
Value: £50,760.00
South32 Limited (di) (S32)
Director name: Warburton,Sharon
Amount purchased: 25,000 @ $3.02
Value: $39,961.91
Apax Global Alpha Limited (APAX)
Director name: Sternberg,Karl
Amount purchased: 27,800 @ 143.70p
Value: £39,948.54
Top Director Sells
Babcock International Group (BAB)
Director name: Mellors,David
Amount sold: 276,512 @ 500.58p
Value: £1,384,150.26